Browsing Tag
Babesia microti
1 post
60 Degrees Pharmaceuticals eyes FDA approval pathway for tafenoquine in babesiosis treatment
60 Degrees Pharmaceuticals targets FDA approval for tafenoquine in babesiosis as January 2027 trial results approach. Explore the risks.